Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC38044 Fraxinellone

    梣酮

    A liminoid degradant with diverse biological activities
  3. GC38037 GSK2983559 free acid A RIPK2 inhibitor
  4. GC38027 Ginkgolide J

    银杏内酯J

    A terpene trilactone with diverse biological activities
  5. GC38014 BT2

    3,6-二氯-2-苯并噻吩羧酸

    An Mcl-1 inhibitor
  6. GA23337 Oxythiamine . HCl

    羟基硫胺盐酸盐

    A thiamine antimetabolite
  7. GA21397 Dolastatin 15

    DLS 15

    A peptide with anticancer activity
  8. GA20897 Boc-Arg(Boc)₂-OH

    三叔丁氧羰基精氨酸

    An amino acid building block
  9. GA20494 Ac-Asp-Glu-Val-Asp-pNA

    Ac-Asp-Glu-Val-Asp-pNA

    A colorimetric caspase substrate
  10. GA20156 (D-Ser(tBu)⁶,Azagly¹⁰)-LHRH (free base)

    戈舍瑞林; ICI 118630

  11. GC45554 Questiomycin A A phenoxazine and chromophore with antibacterial and anticancer activities
  12. GC45550 Pogostone

    广藿香酮

    A pyranone with antifungal and insecticidal activities
  13. GC45549 Pitstop2 Pitstop2是一种网格蛋白抑制剂,可抑制网格蛋白末端结构域的两性结合,IC50值为12μM。
  14. GC45538 Oxychlororaphine

    吩嗪-1-甲酰胺,phenazine-1-carboxamide

    A microbial metabolite with diverse biological activities
  15. GC45536 Oleic Acid-13C

    油酸-1-13C,9-cis-Octadecenoic acid-13C; 9Z-Octadecenoic acid-13C

    An internal standard for the quantification of oleic acid
  16. GC45523 Nemorosone A PPAP with antiproliferative properties
  17. GC45515 MX1013

    CV1013; Z-VD-FMK

    A dipeptide pan-caspase inhibitor
  18. GC45473 Histone H2BK12ac (1-22)-GGK-biotin amide (trifluoroacetate salt)
  19. GC45467 Harzianum A A trichothecene fungal metabolite
  20. GC45414 CRT0066854 A PKCι and PKCζ inhibitor
  21. GC45385 Ara-G

    9-Β-D-糖呋喃鸟嘌呤

    An anticancer nucleoside analog
  22. GC45354 4β-Hydroxywithanolide E

    4BETA-羟基醉茄内酯E

    A withanolide with anti-inflammatory and anticancer activities
  23. GC45353 4-oxo-27-TBDMS Withaferin A A derivative of withaferin A with anticancer activity
  24. GC45352 4-oxo Withaferin A

    4-oxo Withaferin A

    A derivative of withaferin A with anticancer activity
  25. GC45324 2,5-dimethyl Celecoxib

    2,5-二甲基塞来考昔

    An anticancer celecoxib derivative
  26. GC45277 (±)-Camphene

    DL-Camphene, NSC 4165

     
  27. GC45274 (+)-Pinoresinol

    松脂素,(+)-Pinoresinol

    A lignan with diverse biological activities
  28. GC37974 ZYZ-488 ZYZ-488 是一种竞争性凋亡蛋白酶激活因子-1 (Apaf-1) 抑制剂,抑制结合蛋白 procaspase-9 和 procaspase-3 的激活。
  29. GC37964 Zeylenone

    山椒子烯酮

    Zeylenone,可从 Uvaria grandiflora Roxb 的叶子的乙醇萃取物分离。Zeylenone 是一种天然存在的环己烯氧化物,通过 PI3K/AKT/mTOR 和 MAPK/ERK 信号通路抑制宫颈癌细胞增殖并诱导细胞凋亡 (apoptosis)。
  30. GC37900 Verubulin

    (4-甲氧基苯基)(甲基)(2-甲基喹唑啉-4-基)胺,MPC 6827

    Verubulin hydrochloride(MPC 6827 hydrochloride) is a microtubule destabilizer and vascular disrupting agent that achieve high brain concentration relative to plasma in animals.
  31. GC37887 Vanillyl alcohol

    香草醇,p-(Hydroxymethyl)guaiacol

    Vanillyl alcohol (4-Hydroxy-3-methoxybenzyl alcohol, Vanillin alcohol, Vanillic alcohol, 3-Methoxy-4-hydroxybenzyl alcohol), derived from vanillin, is used to flavor food.
  32. GC37873 Ursonic acid

    熊果酮酸; 3-Ketoursolic acid

    Ursonic acid (Prunol, Malol, beta-Ursolic acid, NSC4060, CCRIS 7123, TOS-BB-0966), present in many plants, is a pentacyclic triterpenoid that can be used as a cosmetics additive and serve as a starting material for synthesis of more potent bioactive derivatives, such as experimental antitumor agents. Ursonic acid induces the apoptosis of human cancer cells through multiple signaling pathways.
  33. GC37844 Tubulysin M

    微管蛋白抑制剂 M

    Tubulysin M 是一种高度细胞毒性的肽,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。 Tubulysin 在哺乳动物细胞中显示出极其有效的细胞毒活性,包括多药耐药细胞系,IC50 值在较低的纳摩尔范围内。 Tubulysin M 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  34. GC37843 Tubulysin I

    微管蛋白抑制剂 I

    Tubulysin I 是一种高度细胞毒性的肽,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。 Tubulysin 在哺乳动物细胞中显示出极其有效的细胞毒活性,包括多药耐药细胞系,IC50 值在较低的纳摩尔范围内。 Tubulysin I 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  35. GC37842 Tubulysin H

    微管蛋白抑制剂 H

    Tubulysin H 是一种高度细胞毒性的肽,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。 Tubulysin 在哺乳动物细胞中显示出极其有效的细胞毒活性,包括多药耐药细胞系,IC50 值在较低的纳摩尔范围内。 Tubulysin H 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  36. GC37841 Tubulysin G

    微管蛋白抑制剂 G

    Tubulysin G 是一种高度细胞毒性的肽,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。 Tubulysin 在哺乳动物细胞中显示出极其有效的细胞毒活性,包括多药耐药细胞系,IC50 值在较低的纳摩尔范围内。 Tubulysin G 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  37. GC37840 Tubulysin F

    微管蛋白抑制剂 F

    Tubulysin F 是一种高度细胞毒性的肽,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。 Tubulysin 在哺乳动物细胞中显示出极其有效的细胞毒活性,包括多药耐药细胞系,IC50 值在较低的纳摩尔范围内。 Tubulysin F 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  38. GC37839 Tubulysin E

    微管蛋白抑制剂 E

    Tubulysin E 是一种高度细胞毒性的肽,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。 Tubulysin 在哺乳动物细胞中显示出极其有效的细胞毒活性,包括多药耐药细胞系,IC50 值在较低的纳摩尔范围内。 Tubulysin E 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  39. GC37837 Tubulysin C

    微管蛋白抑制剂 C

    Tubulysin C 是一种高度细胞毒性的肽,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。 Tubulysin 在哺乳动物细胞中显示出极其有效的细胞毒活性,包括多药耐药细胞系,IC50 值在较低的纳摩尔范围内。 Tubulysin C 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  40. GC37836 Tubulysin B Tubulysin B 是一种高度细胞毒性的肽,有效的微管去稳定剂,是从粘细菌 Archangium geophyra 和 Angiococcus disciformis 中分离的。Tubulysin B 抑制许多癌细胞系,包括具有多药抗性的细胞系,IC50 值在皮纳摩尔范围内。Tubulysin B 是一种具有细胞毒性活性微管溶素,抑制微管蛋白聚合并导致细胞周期停滞和凋亡。
  41. GC37798 Tipiracil

    替吡嘧啶

    A potent TPase inhibitor
  42. GC37780 Thevetiaflavone

    黄花夹竹桃黄酮,Apigenin-5-methyl ether

    Thevetiaflavone 可以上调 Bcl?2 的表达,下调 Bax 和 caspase-3 的表达。

  43. GC37765 Terrestrosin D

    蒺藜皂苷D

    Terrestrosin D 是从 Tribulus terrestris L. 中提取得到的一种甾体皂苷,可诱导细胞周期阻滞和癌细胞凋亡。Terrestrosin D 具有抗血管生成的活性。
  44. GC37761 Tenovin-6 Hydrochloride A small molecule activator of p53
  45. GC37745 Taurodeoxycholic acid sodium hydrate

    牛磺猪去氧胆酸,Sodium taurodeoxycholate monohydrate

    Taurodeoxycholic acid sodium hydrate (Sodium taurodeoxycholate monohydrate), a bile acid, is an amphiphilic surfactant molecule synthesized from cholesterol in the liver. It activates S1PR2 pathway in addition to the TGR5 pathway.
  46. GC37715 Taccalonolide A

    根薯酮内酯A

    Taccalonolide A 是一种微管稳定剂,是从 Tacca chantrieri 中分离得到的类固醇,具有细胞毒性和抗疟活性。Taccalonolide A 能引起 G2-M 期滞留、Bcl-2 磷酸化,并引发细胞凋亡。Taccalonolide A 在体外对过表达 p 糖蛋白 (Pgp)、多药耐药蛋白 7 (MRP7) 的细胞系具有显著的抑制作用,抑制SK-OV-3细胞生长的 IC50 值为 622 nM。
  47. GC37688 STAT3-IN-1 STAT3-IN-1 (compound 7d) is an excellent, selective and orally active inhibitor of STAT3 with IC50 of 1.82 μM and 2.14 μM in HT29 and MDA-MB 231 cells, respectively. STAT3-IN-1 induces apoptosis of tumor cells.
  48. GC37678 SS28 SS28是具有口服生物利用度的SRT501 类似物,可抑制微管蛋白聚合,在G2/M引起细胞周期阻滞。SS28会引起细胞凋亡而不是坏死。
  49. GC37669 Soyasapogenol B

    大豆甾醇B

    Soyasapogenol B,大豆的一种成分,具有抗增殖,抗转移活性。Soyasapogenol B 触发内质网应激反应,其介导结肠直肠癌中的细胞凋亡和自噬。
  50. GC37668 Soyasapogenol A

    大豆甾醇A

    Soyasapogenol A 一种三萜化合物,从 Abrus cantoniensis 的根中分离出来。Soyasapogenol A 直接阻止肝细胞凋亡,其次抑制血浆 TNF-α 的升高,从而在刀豆球蛋白 A 诱导的肝炎模型中预防肝损伤。
  51. GC37665 Sorafenib (D4)

    Bay 43-9006-d4

    Sorafenib D4 (Bay 43-9006 D4) 是 Sorafenib 氘代化合物标准品。Sorafenib 是一种多激酶抑制剂,抑制 Raf-1,B-Raf 和 VEGFR-3 的 IC50 分别为6 nM,20 nM,22 nM。

Items 1001 to 1050 of 2517 total

per page

Set Descending Direction